Literature DB >> 21273608

Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis.

Kayoko Takeda1, Ichiro Kinoshita, Yasushi Shimizu, Yoshihiro Matsuno, Toshiaki Shichinohe, Hirotoshi Dosaka-Akita.   

Abstract

BACKGROUND: The Wnt target LGR5 has been recently identified as a murine intestinal stem cell marker. Its role during each stage of human colorectal tumorigenesis remains to be determined. PATIENTS AND METHODS: LGR5 expression was investigated by immunohistochemical analysis in 17 low-grade and 13 high-grade intraepithelial neoplasias and 30 adenocarcinomas.
RESULTS: The number of LGR5-positive cells increased tumor, with clustering of the cells to form patches. An apparent difference in their distribution among the tumorigenesis stages was observed. LGR5 expression in luminal surface showed a negative association with the progressive grade of tumors, while that in lower crypt exhibited a positive association with grade. In adenocarcinomas, LGR5 expression in luminal surface was negatively associated with pStage, while it was almost invariably high in lower crypt during advanced pStage disease.
CONCLUSION: These results suggest that the shifts in the distribution of LGR5-positive cells towards the lower crypt play a role in the development and progression of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273608

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  38 in total

1.  Organ aging and susceptibility to cancer may be related to the geometry of the stem cell niche.

Authors:  Krastan B Blagoev
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.

Authors:  Kirstine Lavrsen; Sally Dabelsteen; Sergey Y Vakhrushev; Asha M R Levann; Amalie Dahl Haue; August Dylander; Ulla Mandel; Lars Hansen; Morten Frödin; Eric P Bennett; Hans H Wandall
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

3.  Logarithmic expansion of LGR5+ cells in human colorectal cancer.

Authors:  Maria Laura Martin; Zhaoshi Zeng; Mohammad Adileh; Adrian Jacobo; Christy Li; Efsevia Vakiani; Guoqiang Hua; Lixing Zhang; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick; Philip B Paty
Journal:  Cell Signal       Date:  2017-09-25       Impact factor: 4.315

4.  Role of Lgr5-positive cells in colorectal cancer.

Authors:  Honghua Ding; Chungang Wang
Journal:  Tumour Biol       Date:  2015-04-03

5.  Lgr5 is a potential prognostic marker in patients with cervical carcinoma.

Authors:  Bo Sun; Xiufeng Ye; Yuan Li; Weiyuan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

6.  Distinct expression profile of stem cell markers, LGR5 and LGR6, in basaloid skin tumors.

Authors:  Bo Gun Jang; Cheol Lee; Hye Sung Kim; Myung Soo Shin; Min Seok Cheon; Jae Wang Kim; Woo Ho Kim
Journal:  Virchows Arch       Date:  2017-01-09       Impact factor: 4.064

7.  Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer.

Authors:  Britta Kleist; Li Xu; Guojun Li; Christian Kersten
Journal:  Int J Clin Exp Pathol       Date:  2011-04-25

8.  A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?

Authors:  Alireza Mirzaei; Gholamreza Tavoosidana; Afshin Abdi Rad; Farhad Rezaei; Masoumeh Tavakoli-Yaraki; Azade Amini Kadijani; Ehsan Khalili; Zahra Madjd
Journal:  Tumour Biol       Date:  2015-09-17

9.  LGR5 is a promising biomarker for patients with stage I and II gastric cancer.

Authors:  Zhaode Bu; Zhixue Zheng; Lianhai Zhang; Ziyu Li; Yu Sun; Bin Dong; Aiwen Wu; Xiaojiang Wu; Xiaohong Wang; Xiaojing Cheng; Xiaofang Xing; Yingai Li; Hong Du; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

10.  LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs.

Authors:  Manal R A Al-Kharusi; Helena J M Smartt; Alexander Greenhough; Tracey J Collard; Elizabeth D Emery; Ann C Williams; Chris Paraskeva
Journal:  Carcinogenesis       Date:  2013-01-24       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.